CO OVA HARUN HE

10
at
12

14
15
16
17
18
19

Item 13 of 19 < a)
a V7 Mark 4 > La

Question Id: 21764

and is therefore prepubertal, warranting further evaluation for a pathologic source of

Previous Next Full Screen Tutorial Lab Values Notes

stimulatory hormones (eg, exogenous medications, testicular/adrenal/pituitary tumor).

(Choice B) Patients with elevated BMI are at risk for both pseudogynecomastia (fatty
infiltration of the breast) as well as true gynecomastia due to increased activity of aromatase in
obese males. This patient has a normal BMI.

Educational objective:

Adolescent gynecomastia is often physiologic due to an imbalance of estrogens and
testosterone in early puberty. Features suggestive of pathologic gynecomastia include onset
before or after midpuberty (eg, no secondary sexual characteristics), findings consistent with
systemic illness (eg, goiter), as well as size >4 cm, rapid progression, and location eccentric to
the nipple areolar complex.

References
e¢ Management of adolescent gynecomastia: an update.

Pathophysiology Endocrine, Diabetes & Metabolism Gynecomastia
Subject ‘System Topic
Copyright © UWorld. Alll rights reserved

Text Zoom

Activate Windows

Settings

nd

End Block
